Skip to main content
SpringerLink
Log in

Lower levels of total HDL and HDL3 cholesterol are associated with albuminuria in normoalbuminuric Type 1 diabetic patients

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Previous studies have suggested a positive association between dyslipidemia and chronic kidney disease, but sparse data are available on the relation of lipids and urinary albumin excretion rate (UAE) in normoalbuminuric patients with normal renal function. Aim: The aim of this study was to evaluate the associations of serum lipids, including total, LDL, HDL, HDL2, HDL3 cholesterol, and triglyceride levels with UAE in normoalbuminuric Type 1 diabetic (T1D) patients. Methods: Study included 313 normoalbuminuric T1D patients with normal renal function and before any interventions with statins, ACE inhibitors or angiotensin II receptor blockers. Subjects were classified as low-normoalbuminuric (UAE<11.0 mg/24h) or high-normoalbuminuric (UAE≥11.0 mg/24h) based on median UAE of at least two 24-h urine collections. Correlations and multiple linear regressions analysis were performed to identify relationships between serum lipids and UAE in normoalbuminuric subjects. Results: Total HDL (p=0.02) and HDL3 cholesterol (p=0.01) levels were higher in low-normoalbuminuric subjects compared to high-normoalbuminuric subjects. In logistic regression analysis, after adjustment for age, sex, BMI, duration of diabetes and HbA1c, lower total HDL and HDL3 cholesterol levels were significantly associated with risk of higher UAE in our normoalbuminuric subjects (p≤0.01), with odds ratios of 0.34 to 0.43. Conclusions: Elevated total HDL and HDL3 cholesterol levels are associated with lower UAE in normoalbuminuric T1D patients. However, whether the detection of elevated total HDL and HDL3 cholesterol levels in T1D patients has protective value for development of microalbuminuria needs to be assessed in further follow-up studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes: the Linkoping Diabetes Complications Study. Diabetologia 2004, 47: 1266–72.

    Article  PubMed  Google Scholar 

  2. Raile K, Galler A, Hofer S, et al. Diabetic nephropathy in 27, 805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007, 30: 2523–8.

    Article  PubMed  Google Scholar 

  3. Coonrod BA, Ellis D, Becker DJ, et al. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 1993, 16: 1376–83.

    Article  PubMed  Google Scholar 

  4. Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995, 332: 1251–5.

    Article  PubMed  Google Scholar 

  5. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med 2003, 254: 45–66.

    Article  PubMed  Google Scholar 

  6. Scott LJ, Warram JH, Hanna LS, Laffel LM, Ryan L, Krolewski AS. A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 2001, 50: 2842–9.

    Article  PubMed  Google Scholar 

  7. Lahdenpera S, Groop PH, Tilly-Kiesi M, et al. LDL subclasses in IDDM patients: Relation to diabetic nephropathy. Diabetologia 1994, 37: 681–8.

    Article  PubMed  Google Scholar 

  8. Sibley SD, Hokanson JE, Steffes MW, et al. Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care 1999, 22: 1165–70.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Shepherd J, Kastelein JJ, Bittner V, et al. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The treating to new targets (TNT) study. Clin J Am Soc Nephrol 2007, 2: 1131–9.

    Article  PubMed  Google Scholar 

  10. Orchard TJ, Chang Y, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002, 62: 963–70.

    Article  PubMed  Google Scholar 

  11. Tolonen N, Forsblom C, Thorn L, et al. Relationship between lipid profiles and kidney function in patients with type 1 diabetes. Diabetologia 2008, 51: 12–20.

    Article  PubMed  Google Scholar 

  12. Chaturvedi N, Fuller JH, Taskinen MR. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications in type 1 diabetes. Diabetes Care 2001, 24: 2071–7.

    Article  PubMed  Google Scholar 

  13. Marcovecchio ML, Dalton RN, Prevost AT, et al. Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care 2009, 32: 658–63.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Dullaart R, Dikkeschei L, Doorenbos H. Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1989, 32: 685–9.

    PubMed  Google Scholar 

  15. Thomas MC, Rosengard-Bärlund M, Mills V, et al. Serum lipids and the progression of nephropathy in type 1 diabetes. Diabetes Care 2006, 29: 317–22.

    Article  PubMed  Google Scholar 

  16. Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diabet Med 2000, 26: 254–64.

    Google Scholar 

  17. Hirano T, Naito H, Kurokawa M, et al. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy. Atherosclerosis 1996, 123: 57–72.

    Article  PubMed  Google Scholar 

  18. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003, 348: 2285–93.

    Article  PubMed  Google Scholar 

  19. Groop PH, Thomas MC, Rosengard-Bärlund M, et al. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care 2007, 30: 2706–7.

    Article  PubMed  Google Scholar 

  20. Molitch ME, Rupp D, Carnethon M. Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes. Diabetes Care 2006, 29: 78–82.

    Article  PubMed  Google Scholar 

  21. Tolonen N, Forsblom C, Thorn J, et al. Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia 2009, 52: 2522–30.

    Article  PubMed  Google Scholar 

  22. Bulum T, Duvnjak L, Prkacin I. Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes. Acta Med Croatica 2011, 65: 243–50.

    PubMed  Google Scholar 

  23. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286: 421–6.

    Article  PubMed  Google Scholar 

  24. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150: 604–12.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Standards of Medical Care in Diabetes — 2012. Diabetes Care 2012, 35(Suppl. 1): S11–63.

    Google Scholar 

  26. Hovind P, Tarnow L, Rossing P, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 2004, 328: 1105.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Epidemiology of Diabetes Interventions and Complications (EDIC)/Diabetes Control and Complications Trial (DCCT) Study Group: Sustained effects of intensive treatment of type 1 diabetes mellitus on the development and progression of diabetic nephropathy. JAMA 2003, 290: 2159–67.

    Article  Google Scholar 

  28. Jenkins AJ, Lyons TJ, Zheng D, et al. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int 2003, 64: 817–28.

    Article  PubMed  Google Scholar 

  29. Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC. The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 1999, 22: 743–51.

    Article  PubMed  Google Scholar 

  30. Genest J jr. Genetics and prevention: a new look at high-density lipoprotein cholesterol. Cardiol Rev 2002, 10: 61–71.

    Article  PubMed  Google Scholar 

  31. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285: 2486–96.

    Article  Google Scholar 

  32. Kahri J, Groop PH, Elliott T, Viberti G, Taskinen MR. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-1-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy. Diabetes Care 1994, 17: 412–9.

    Article  PubMed  Google Scholar 

  33. Barter PJ, Rye KA. High density lipoproteins and coronary heart disease. Atherosclerosis 1996, 121: 1–12.

    Article  PubMed  Google Scholar 

  34. Yu S, Yarnell JWG, Sweetnam P, Bolton CH. High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study. Atherosclerosis 2003, 166: 331–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vuk Vrhovac Clinic for Diabetes, Endocrinology and Metabolic Diseases, University Hospital Merkur, School of Medicine, University of Zagreb, Zagreb, Croatia

    T. Bulum MD, PhD & L. Duvnjak

  2. Medical School, University of Rijeka, Rijeka, Croatia

    B. Kolarić

  3. Zagreb County Institute of Public Health, Zagreb, Croatia

    B. Kolarić

Authors
  1. T. Bulum MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Kolarić
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Duvnjak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Bulum MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bulum, T., Kolarić, B. & Duvnjak, L. Lower levels of total HDL and HDL3 cholesterol are associated with albuminuria in normoalbuminuric Type 1 diabetic patients. J Endocrinol Invest 36, 574–578 (2013). https://doi.org/10.3275/8850

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/8850

Key-words

Search

Navigation